Craniopharyngioma

Endocrine Reviews

Volumn 35, Issue 3, 2014, Pages 513-543

  Müller, Hermann L ^a  

^a KLINIKUM OLDENBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; COGNITIVE DEFECT; CRANIOPHARYNGIOMA; DISEASE COURSE; HUMAN; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; INCIDENCE; INTRACRANIAL HYPERTENSION; OBESITY; ONSET AGE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; SYMPTOMATOLOGY; TREATMENT INDICATION; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR RECURRENCE; VISUAL IMPAIRMENT; PITUITARY NEOPLASMS;

CRANIOPHARYNGIOMA; HUMANS; PITUITARY NEOPLASMS;

EID: 84901493311     PISSN: None     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2013-1115     Document Type: Review

References (294)

1. WisoffJH, Donahue BR. Craniopharyngiomas. In: Albright AL, Pollack IF, Adelson PD, eds. Principles and Practice of Pediatric Neurosurgery. 2nd ed. New York, Stuttgart: Thieme; 2006:560-577.
2. Müller HL. Childhood craniopharyngioma-current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol. 2010;6:609-618.
3. Müller HL. Childhood craniopharyngioma: current controversies on management in diagnostics, treatment and follow-up. Expert Rev Neurother. 2010;10:515-524.
4. Müller HL. Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res. 2008;69:193-202.
5. Karavitaki N, Cudlip S, Adams CB, Wass JA. Craniopharyngiomas. Endocr Rev. 2006;27:371-397.
6. Müller HL. Paediatrics: surgical strategy and quality of life in craniopharyngioma. Nat Rev Endocrinol. 2013;9:447-449.
7. Tomlinson JW, Holden N, Hills RK, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet. 2001;357:425-431.
8. Erfurth EM, Holmer H, Fjalldal SB. Mortality and morbidity in adult craniopharyngioma. Pituitary. 2013;16:46-55.
9. Müller HL. Diagnostics, treatment, and follow-up in craniopharyngioma. Front Endocrinol (Lausanne). 2011; 2:70.
10. Müller HL, Gebhardt U, Etavard-Gorris N, et al. Prognosis and sequela in patients with childhood craniopharyngioma - results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000. Klin Padiatr. 2004;216:343-348.
11. Müller HL. Childhood craniopharyngioma. Pituitary. 2013;16:56-67.
12. von Mohr U. Hypertrophie der Hypophysis Cerebri und dadurch bedingter Druck auf die Hirngrundfläche, insbesondere auf die Sehnerven, das Chiasma desselben und den linksseitigen Hirnschenkel. Wochenschr Ges Heilkd. 1840;6:556-571.
13. Raimondi AJ, Rougerie J. 1994 A critical review of personal experiences with craniopharyngioma: clinical history, surgical technique and operative results. 1983. Pediatr Neurosurg. 1994;21:134-150; discussion 151-154.
14. Luschka H. Der gehirnanhang und die steissdrüse des menschen. Berlin: G. Reimer; 1860.
15. Saxer F. Ependymepithel, gliome und epithlische geschwülste des zentralen nervensystems. Ziegler's Beiträge. 1902;32:276.
16. Erdheim J. Über Hypophysengangsgeschwulste und Hirncholesteatome. Sitzungsber Akad Wiss Wien. 1904;113:537-726.
17. Susman W. Embryonic epithelial rests in the pituitary. Br J Surg. 1932;19:571-576.
18. Lewis DD. A contribution to the subject of tumours of the hypophysis. JAMA. 1910;55:1002-1008.
19. Cushing H. The craniopharyngioma. Intracranial tumours. London: Bailiere, Tindall and Cox; 1932:93-98.
20. Nielsen EH, Feldt-Rasmussen U, Poulsgaard L, et al. Incidence of craniopharyngioma in Denmark (n ç 189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol. 2011;104:755-763.
21. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg. 1998;89:547-551.
22. Matson DD, Crigler JF Jr. Management of craniopharyngioma in childhood. J Neurosurg. 1969;30:377-390.
23. Schoenberg BS, Schoenberg DG, Christine BW, Gomez MR. The epidemiology of primary intracranial neoplasms of childhood. A population study. Mayo Clin Proc. 1976; 51:51-56.
24. Kuratsu J, Ushio Y. Epidemiological study of primary intracranial tumors in childhood. Apopulation-based survey in Kumamoto Prefecture, Japan. Pediatr Neurosurg. 1996; 25:240-246; discussion 247.
25. Müller-Scholden J, Lehrnbecher T, Müller HL, et al. Radical surgery in a neonate with craniopharyngioma. report of a case. Pediatr Neurosurg. 2000;33:265-269.
26. Larkin SJ, Ansorge O. Pathology and pathogenesis of craniopharyngiomas. Pituitary. 2013;16:9-17.
27. Rushing EJ, Giangaspero F, Paulus W, Burger PC. Craniopharyngioma. In: Louis DN, Ohgaki H, Wiestler OD, Webster KC, eds. WHO Classification of Tumours of the Central Nervous System. 3rd ed. Geneva, Switzerland:World Health Organization Press. 2007; 238-240.
28. Bailey W, Freidenberg GR, James HE, Hesselink JR, Jones KL. Prenatal diagnosis of a craniopharyngioma using ultrasonography and magnetic resonance imaging. Prenat Diagn. 1990;10:623-629.
29. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. Neurosurg Focus. 1997;3:e1.
30. Sorva R, Heiskanen O. Craniopharyngioma in Finland. A study of 123 cases. Acta Neurochir (Wien). 1986;81:85-89.
31. Boch AL, van Effenterre R, KujasM. Craniopharyngiomas intwoconsanguineous siblings: case report. Neurosurgery. 1997;41:1185-1187.
32. Green AL, Yeh JS, Dias PS. Craniopharyngioma in a mother and daughter. Acta Neurochir (Wien). 2002;144:403-404.
33. Müller HL, Kaatsch P, Warmuth-Metz M, Flentje M, Sorensen N. Childhood craniopharyngioma - diagnostic and therapeutic strategies. Monatsschr Kinderheilkd. 2003; 151:1056-1063.
34. Sherlock M, Ayuk J, Tomlinson JW, et al. Mortality in patients with pituitary disease. Endocr Rev. 2010;31:301-342.
35. Górski GK, McMorrow LE, Donaldson MH, Freed M. Multiple chromosomal abnormalities in a case of craniopharyngioma. Cancer Genet Cytogenet. 1992;60:212-213.
36. Karnes PS, Tran TN, Cui MY, et al. Cytogenetic analysis of 39 pediatric central nervous system tumors. Cancer Genet Cytogenet. 1992;59:12-19.
37. Buslei R, Nolde M, Hofmann B, et al. Common mutations of β-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol. 2005;109:589-597.
38. Kato K, Nakatani Y, Kanno H, et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol. 2004;203:814-821.
39. Oikonomou E, Barreto DC, Soares B, De Marco L, Buchfelder M, Adams EF. β-Catenin mutations in craniopharyngiomas and pituitary adenomas. J Neurooncol. 2005; 73:205-209.
40. Sekine S, Shibata T, Kokubu A, et al. Craniopharyngiomas of adamantinomatous type harbor β-catenin gene mutations. Am J Pathol. 2002;161:1997-2001.
41. Rickert CH, Paulus W. Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngiomas. J Neurol Neurosurg Psychiatry. 2003;74:260-261.
42. Yoshimoto M, de Toledo SR, da Silva NS, et al. Comparative genomic hybridization analysis of pediatric adamantinomatous craniopharyngiomas and a review of the literature. J Neurosurg. 2004;101:85-90.
43. Rienstein S, AdamsEF, Pilzer D, Goldring AA, Goldman B, Friedman E. Comparative genomic hybridization analysis of craniopharyngiomas. J Neurosurg. 2003;98:162-164.
44. Garrè ML, Cama A. Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr Opin Pediatr. 2007;19:471-479.
45. Nozza P, Gambini C. Paediatric craniopharyngioma: a pathological review. J Pediatr Endocrinol Metab. 2006; 19(suppl 1):295-298.
46. Sartoretti-Schefer S, Wichmann W, Aguzzi A, Valavanis A. MR differentiation of adamantinous and squamous-papillary craniopharyngiomas. AJNR Am J Neuroradiol. 1997;18:77-87.
47. Sato K, Oka H, Utsuki S, Kondo K, Kurata A, Fujii K. Ciliated craniopharyngioma may arise from Rathke cleft cyst. Clin Neuropathol. 2006;25:25-28.
48. Powers CJ, New KC, McLendon RE, Friedman AH, Fuchs HE. Cerebellopontine angle craniopharyngioma: case report and literature review. Pediatr Neurosurg. 2007;43:158-163.
49. Hassanein AM, Glanz SM, Kessler HP, Eskin TA, Liu C. β-Catenin is expressed aberrantly in tumors expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst. Am J Clin Pathol. 2003;120:732-736.
50. Hofmann BM, Kreutzer J, Saeger W, et al. Nuclear β-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach. Am J Surg Pathol. 2006;30:1595-1603.
51. Buslei R, Hölsken A, Hofmann B, et al. Nuclear β-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol. 2007;113:585-590.
52. Gaston-Massuet C, Andoniadou CL, Signore M, et al. Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci USA. 2011;108:11482-11487.
53. Dattani MT, Martinez-Barbera JP, Thomas PQ, et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet. 1998;19:125-133.
54. Andoniadou CL, Gaston-Massuet C, Reddy R, et al. Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma. Acta Neuropathol. 2012;124:259-271.
55. Petito CK, DeGirolami U, Earle KM. Craniopharyngiomas:a clinical and pathological review. Cancer. 1976;37:1944-1952.
56. Harwood-Nash DC. Neuroimaging of childhood craniopharyngioma. Pediatr Neurosurg. 1994;21(suppl 1):2-10.
57. Karavitaki N, Brufani C, Warner JT, et al. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf). 2005;62:397-409.
58. Graziani N, Donnet A, Bugha TN, Dufour H, Figarella-Branger D, Grisoli F. Ectopic basisphenoidal craniopharyngioma:case report and review of the literature. Neurosurgery. 1994;34:346-349; discussion 349.
59. Akimura T, Kameda H, Abiko S, Aoki H, Kido T. Infrasellar craniopharyngioma. Neuroradiology. 1989;31:180-183.
60. Cooper PR, RansohoffJ. Craniopharyngioma originating in the sphenoid bone. Case report. J Neurosurg. 1972;36:102-106.
61. Jiang RS, Wu CY, Jan YJ, Hsu CY. Primary ethmoid sinus craniopharyngioma: a case report. J Laryngol Otol. 1998; 112:403-405.
62. DuffTA, Levine R. Intrachiasmatic craniopharyngioma. Case report. J Neurosurg. 1983;59:176-178.
63. Sohn CH, Baik SK, Kim SP, Kim IM, Sevick RJ. Craniopharyngioma in the temporal lobe: a case report. Korean J Radiol. 2004;5:72-74.
64. Solarski A, Panke ES, Panke TW. Craniopharyngioma in the pineal gland. Arch Pathol Lab Med. 1978;102:490-491.
65. Bashir EM, Lewis PD, Edwards MR. Posterior fast craniopharyngioma. Br J Neurosurg. 1996;10:613-615.
66. Altinörs N, Senveli E, Erdogan A, Arda N, Pak I. Craniopharyngioma of the cerebellopontine angle. Case report. J Neurosurg. 1984;60:842-844.
67. Waga S, Morikawa A, Sakakura M. Craniopharyngioma with midbrain involvement. Arch Neurol. 1979;36:319-320.
68. Davies MJ, King TT, Metcalfe KA, Monson JP. Intraventricular craniopharyngioma: a long-term follow-up of six cases. Br J Neurosurg. 1997;11:533-541.
69. Caldarelli M, Massimi L, Tamburrini G, Cappa M, Di Rocco C. Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome. Child Nerv Syst. 2005; 21:747-757.
70. Hoffman HJ, De Silva M, Humphreys RP, Drake JM, Smith ML, Blaser SI. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg. 1992;76:47-52.
71. Mortini P, Gagliardi F, Boari N, Losa M. Surgical strategies and modern therapeutic options in the treatment of craniopharyngiomas. Crit Rev Oncol Hematol. 2013;88:514-529.
72. Müller HL, Emser A, Faldum A, et al. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab. 2004;89:3298-3305.
73. Warmuth-Metz M, Gnekow AK, Müller H, Solymosi L. Differential diagnosis of suprasellar tumors in children. Klin Padiatr. 2004;216:323-330.
74. Müller HL. Craniopharyngioma - a childhood and adult disease with challenging characteristics. Front Endocrinol (Lausanne). 2012;3:80.
75. Hald JK, Eldevik OP, Skalpe IO. Craniopharyngioma identification by CT and MR imaging at 1.5 T. Acta Radiol. 1995;36:142-147.
76. Famini P, Maya MM, Melmed S. Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab. 2011;96:1633-1641.
77. Müller HL, Gebhardt U, Faldum A, et al. Xanthogranuloma, Rathke's cyst, and childhood craniopharyngioma:results of prospective multinational studies of children and adolescents with rare sellar malformations. J Clin Endocrinol Metab. 2012;97:3935-3943.
78. Choux M, Lena G. Bases of surgical management of craniopharyngioma in children [proceedings]. Acta Neurochir Suppl (Wien). 1979;28:348.
79. Flitsch J, Müller HL, Burkhardt T. Surgical strategies in childhood craniopharyngioma. Front Endocrinol (Lausanne). 2011;2:96.
80. Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg. 1999;90:237-250.
81. Buchfelder M, Schlaffer SM, Lin F, Kleindienst A. Surgery for craniopharyngioma. Pituitary. 2013;16:18-25.
82. Müller HL. Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab. 2011;96:1981-1991.
83. Müller HL. More or less? Treatment strategies in childhood craniopharyngioma. Childs Nerv Syst. 2006;22:156-157.
84. Müller HL, Gebhardt U, Pohl F, et al. Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma. Klin Padiatr. 2006;218:315-320.
85. Kordes U, Flitsch J, Hagel C, et al. Ectopic craniopharyngioma. Klin Padiatr. 2011;223:176-177.
86. Becker G, Kortmann RD, Skalej M, Bamberg M. The role of radiotherapy in the treatment of craniopharyngioma-indications, results, side effects. Front Radiat Ther Oncol. 1999;33:100-113.
87. Elowe-Gruau E, Beltrand J, Brauner R, et al. Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab. 2013; 98:2376-2382.
88. Puget S, Grill J, Habrand JL, Sainte-Rose C. Multimodal treatment of craniopharyngioma: defining a risk-adapted strategy. J Pediatr Endocrinol Metab. 2006;19(suppl 1):367-370.
89. Vinchon M, Weill J, Delestret I, Dhellemmes P. Craniopharyngioma and hypothalamic obesity in children. Childs Nerv Syst. 2009;25:347-352.
90. Hetelekidis S, Barnes PD, Tao ML, et al. 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys. 1993;27:189-195.
91. Rajan B, Ashley S, Gorman C, et al. Craniopharyngioma-a long-term results following limited surgery and radiotherapy. Radiother Oncol. 1993;26:1-10.
92. Merchant TE, Kiehna EN, Sanford RA, et al. Craniopharyngioma:the St. Jude Children's Research Hospital experience 1984-2001. Int J Radiat Oncol Biol Phys. 2002; 53:533-542.
93. Koutourousiou M, Gardner PA, Fernandez-Miranda JC, Tyler-Kabara EC, Wang EW, Snyderman CH. Endoscopic endonasal surgery for craniopharyngiomas: surgical outcome in 64 patients. J Neurosurg. 2013;119:1194-1207.
94. Oppido PA, Fiorindi A, Benvenuti L, et al. Neuroendoscopic biopsy of ventricular tumors: a multicentric experience. Neurosurg Focus. 2011;30:E2.
95. Liu JK, Christiano LD, Gupta G, Carmel PW. Surgical nuances for removal of retrochiasmatic craniopharyngiomas via the transbasal subfrontal translamina terminalis approach. Neurosurg Focus. 2010;28:E6.
96. Liu JK, Christiano LD, Patel SK, Eloy JA. Surgical nuances for removal of retrochiasmatic craniopharyngioma via the endoscopic endonasal extended transsphenoidal transplanum transtuberculum approach. Neurosurg Focus. 2011; 30:E14.
97. Maira G, Anile C, Colosimo C, Cabezas D. Craniopharyngiomas of the third ventricle: trans-lamina terminalis approach. Neurosurgery. 2000;47:857-863; discussion 863-865.
98. Konovalov AN. Microsurgery of tumours of diencephalic region. Neurosurg Rev. 1983;6:37-41.
99. Abe T, Ludecke DK. Recent results of primary transnasal surgery for infradiaphragmatic craniopharyngioma. Neurosurg Focus. 1997;3:e4.
100. Yamada S, Fukuhara N, Oyama K, et al. Surgical outcome in 90 patients with craniopharyngioma: an evaluation of transsphenoidal surgery. World Neurosurg. 2010;74:320-330.
101. Gardner PA, Kassam AB, Snyderman CH, et al. Outcomes following endoscopic, expanded endonasal resection of suprasellar craniopharyngiomas: a case series. J Neurosurg. 2008;109:6-16.
102. Jane JA Jr, Kiehna E, Payne SC, Early SV, LawsERJr. Early outcomes of endoscopic transsphenoidal surgery for adult craniopharyngiomas. Neurosurg Focus. 2010;28:E9.
103. Sanford RA. Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery. Pediatr Neurosurg.1994;21(suppl 1):39-43.
104. Müller HL, Gebhardt U, Teske C, et al. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma:results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol. 2011;165:17-24.
105. Dehdashti AR, Karabatsou K, Ganna A, Witterick I, Gentili F. Expanded endoscopic endonasal approach for treatment of clival chordomas: early results in 12 patients. Neurosurgery.2008;63:299-307; discussion 307-299.
106. Kortmann RD. Different approaches in radiation therapy of craniopharyngioma. Front Endocrinol (Lausanne).2011;2:100.
107. Aggarwal A, Fersht N, Brada M. Radiotherapy for craniopharyngioma. Pituitary. 2013;16:26-33.
108. Habrand JL, Saran F, Alapetite C, Noel G, El Boustany R, Grill J. Radiation therapy in the management of craniopharyngioma:current concepts and future developments. J Pediatr Endocrinol Metab. 2006;19(suppl 1):389-394.
109. Minniti G, Esposito V, Amichetti M, Enrici RM. The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma. Neurosurg Rev. 2009;32:125-132; discussion 132.
110. Merchant TE, Kiehna EN, Kun LE, et al. Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J Neurosurg. 2006;104:94-102.
111. IannalfiA, Fragkandrea I, Brock J, Saran F. Radiotherapy in craniopharyngiomas. Clin Oncol (R Coll Radiol). 2013; 25:654-667.
112. Kiehna EN, Merchant TE. Radiation therapy for pediatric craniopharyngioma. Neurosurg Focus. 2010;28:E10.
113. Merchant TE. Craniopharyngioma radiotherapy: endocrine and cognitive effects. J Pediatr Endocrinol Metab. 2006;19(suppl 1):439-446.
114. Beltran C, Naik M, Merchant TE. Dosimetric effect of target expansion and setup uncertainty during radiation therapy in pediatric craniopharyngioma. Radiother Oncol. 2010;97:399-403.
115. Merchant TE, KunLE, HuaCH, et al. Disease control after reduced volume conformal and intensity modulated radiation therapy for childhood craniopharyngioma. Int J Radiat Oncol Biol Phys. 2013;85:e187-e192.
116. Carmel PW, Antunes JL, Chang CH. Craniopharyngiomas in children. Neurosurgery. 1982;11:382-389.
117. Habrand JL, Ganry O, Couanet D, et al. The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys. 1999;44:255-263.
118. Flickinger JC, Lunsford LD, Singer J, Cano ER, Deutsch M. Megavoltage external beam irradiation of craniopharyngiomas:analysis of tumor control and morbidity. Int J Radiat Oncol Biol Phys. 1990;19:117-122.
119. Mark RJ, Lutge WR, Shimizu KT, Tran LM, Selch MT, Parker RG. Craniopharyngioma: treatment in the CT and MR imaging era. Radiology. 1995;197:195-198.
120. Varlotto JM, Flickinger JC, Kondziolka D, Lunsford LD, Deutsch M. External beam irradiation of craniopharyngiomas:long-term analysis of tumor control and morbidity. Int J Radiat Oncol Biol Phys. 2002;54:492-499.
121. Pemberton LS, Dougal M, Magee B, Gattamaneni HR. Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma. Radiother Oncol. 2005;77:99-104.
122. Combs SE, Thilmann C, Huber PE, Hoess A, Debus J, Schulz-Ertner D. Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy. Cancer. 2007;109:2308-2314.
123. Minniti G, Saran F, Traish D, et al. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol. 2007;82:90-95.
124. Kanesaka N, Mikami R, Nakayama H, et al. Preliminary results of fractionated stereotactic radiotherapy after cyst drainage for craniopharyngioma in adults. Int J Radiat Oncol Biol Phys. 2012;82:1356-1360.
125. Hashizume C, Mori Y, Kobayashi T, Shibamoto Y, Nagai A, Hayashi N. Stereotactic radiotherapy using Novalis for craniopharyngioma adjacent to optic pathways. J Neurooncol. 2010;98:239-247.
126. Selch MT, DeSalles AA, Wade M, et al. Initial clinical results of stereotactic radiotherapy for the treatment of craniopharyngiomas. Technol Cancer Res Treat. 2002; 1:51-59.
127. Winkfield KM, Linsenmeier C, Yock TI, et al. Surveillance of craniopharyngioma cyst growth in children treated with proton radiotherapy. Int J Radiat Oncol Biol Phys. 2009; 73:716-721.
128. Fitzek MM, Linggood RM, Adams J, Munzenrider JE. Combined proton and photon irradiation for craniopharyngioma:long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital. Int J Radiat Oncol Biol Phys. 2006; 64:1348-1354.
129. Luu QT, Loredo LN, Archambeau JO, Yonemoto LT, Slater JM, Slater JD. Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report. Cancer J. 2006;12:155-159.
130. Boehling NS, Grosshans DR, Bluett JB, et al. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensi-ty-modulated radiotherapy for treatment of pediatric craniopharyngiomas. Int J Radiat Oncol Biol Phys. 2012;82:643-652.
131. Beltran C, RocaM, Merchant TE. Onthe benefits and risks of proton therapy in pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys. 2012;82:e281-e287.
132. Laffond C, Dellatolas G, Alapetite C, et al. Quality-of-life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy. Brain Inj. 2012;26:270-281.
133. Tarbell NJ, Barnes P, Scott RM, et al. Advances in radiation therapy for craniopharyngiomas. Pediatr Neurosurg. 1994;21(suppl 1):101-107.
134. Schubert T, TrippelM, Tacke U, et al. Neurosurgical treatment strategies in childhood craniopharyngiomas: is less more? Childs Nerv Syst. 2009;25:1419-1427.
135. Schulz-Ertner D, Frank C, Herfarth KK, Rhein B, Wannenmacher M, Debus J. Fractionated stereotactic radiotherapy for craniopharyngiomas. Int J Radiat Oncol Biol Phys. 2002;54:1114-1120.
136. Lee M, Kalani MY, Cheshier S, Gibbs IC, Adler JR, Chang SD. Radiation therapy and CyberKnife radiosurgery in the management of craniopharyngiomas. Neurosurg Focus. 2008;24:E4.
137. Mokry M. Craniopharyngiomas: a six year experience with gamma knife radiosurgery. Stereotact Funct Neurosurg. 1999;72(suppl 1):140-149.
138. Chung WY, Pan DH, Shiau CY, Guo WY, Wang LW. Gamma knife radiosurgery for craniopharyngiomas. J Neurosurg. 2000;93(suppl 3):47-56.
139. Amendola BE, Wolf A, Coy SR, Amendola MA. Role of radiosurgery in craniopharyngiomas: a preliminary report. Med Pediatr Oncol. 2003;41:123-127.
140. Kobayashi T. Long-term results of gamma knife radiosurgery for 100 consecutive cases of craniopharyngioma and a treatment strategy. Prog Neurol Surg. 2009;22:63-76.
141. Prasad D, Steiner M, Steiner L. Gamma knife surgery for craniopharyngioma. Acta Neurochir (Wien). 1995;134:167-176.
142. Chiou SM, Lunsford LD, Niranjan A, Kondziolka D, Flickinger JC. Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy. Neuro Oncol. 2001;3:159-166.
143. Ulfarsson E, Lindquist C, Roberts M, et al. Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients. J Neurosurg. 2002;97:613-622.
144. Yu X, Liu Z, Li S. Combined treatment with stereotactic intracavitary irradiation and gamma knife surgery for craniopharyngiomas. Stereotact Funct Neurosurg. 2000;75:117-122.
145. Leksell L, Backlund EO, Johansson L. Treatment of craniopharyngiomas. Acta Chir Scand. 1967;133:345-350.
146. Szeifert GT, Julow J, Slowik F, Bálint K, Lányi F, Pásztor E. Pathological changes in cystic craniopharyngiomas following intracavital 90yttrium treatment. Acta Neurochir (Wien). 1990;102:14-18.
147. Derrey S, Blond S, Reyns N, et al. Management of cystic craniopharyngiomas with stereotactic endocavitary irradiation using colloidal 186Re: a retrospective study of 48 consecutive patients. Neurosurgery. 2008;63:1045-1052; discussion 1052-1043.
148. Backlund EO. Studies on craniopharyngiomas. IV. Stereotaxic treatment with radiosurgery. Acta Chir Scand. 1973; 139:344-351.
149. Pollock BE, Lunsford LD, Kondziolka D, Levine G, Flickinger JC. Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results. Int J Radiat Oncol Biol Phys. 1995;33:437-446.
150. Voges J, Sturm V, Lehrke R, Treuer H, Gauss C, Berthold F. Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal β-emitting radioactive sources. Neurosurgery. 1997; 40:263-269; discussion 269-270.
151. Bond WH, Richards D, Turner E. Experiences with radioactive gold in the treatment of craniopharyngioma. J Neurol Neurosurg Psychiatry. 1965;28:30-38.
152. Van den Berge JH, Blaauw G, Breeman WA, Rahmy A, Wijngaarde R. Intracavitary brachytherapy of cystic craniopharyngiomas. J Neurosurg. 1992;77:545-550.
153. Hasegawa T, Kondziolka D, Hadjipanayis CG, Lunsford LD. Management of cystic craniopharyngiomas with phosphorus-32 intracavitary irradiation. Neurosurgery. 2004;54:813-820; discussion 820-812.
154. Blackburn TP, Doughty D, Plowman PN. Stereotactic intracavitary therapy of recurrent cystic craniopharyngioma by instillation of 90yttrium. Br J Neurosurg. 1999;13:359-365.
155. Vanhauwaert D, Hallaert G, Baert E, Van Roost D, Okito JP, Caemaert J. Treatment of cystic craniopharyngioma by endocavitary instillation of yttrium90 radioisotope-still a valuable treatment option. J Neurol Surg A Cent Eur Neurosurg. 2013;74:307-312.
156. Julow J, Lányi F, Hajda M, Szeifert G, Simkovits M, Pásztor E. Intracystic instillation of yttrium 90 silicate colloid in cystic craniopharyngioma [in Hungarian]. Orv Hetil. 1989;130:1367-1368, 1371-1375.
157. SzeifertGT, Bálint K, Sipos L, SarkerMH, Czirják S, Julow J. Pathological findings in cystic craniopharyngiomas after stereotactic intracavitary irradiation with yttrium-90 isotope. Prog Neurol Surg. 2007;20:297-302.
158. Steinbok P, Hukin J. Intracystic treatments for craniopharyngioma. Neurosurg Focus. 2010;28:E13.
159. Barriger RB, Chang A, Lo SS, et al. Phosphorus-32 therapy for cystic craniopharyngiomas. Radiother Oncol. 2011; 98:207-212.
160. Linnert M, Gehl J. Bleomycin treatment of brain tumors:an evaluation. Anticancer Drugs. 2009;20:157-164.
161. Cavalheiro S, Sparapani FV, Franco JO, da Silva MC, Braga FM. Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. Case report. J Neurosurg. 1996;84:124-126.
162. Kim SD, Park JY, Park J, Lee JB, Kim SH, Lim DJ. Radiological findings following postsurgical intratumoral bleomycin injection for cystic craniopharyngioma. Clin Neurol Neurosurg. 2007;109:236-241.
163. Takahashi H, Nakazawa S, Shimura T. Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children. J Neurosurg. 1985;62:120-127.
164. Hader WJ, Steinbok P, Hukin J, Fryer C. Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children. Pediatr Neurosurg. 2000;33:211-218.
165. Mottolese C, Stan H, Hermier M, et al. Intracystic chemo therapy with bleomycin in the treatment of craniopharyngiomas. Childs Nerv Syst. 2001;17:724-730.
166. ParkDH, Park JY, KimJH, et al. Outcomeof postoperative intratumoral bleomycin injection for cystic craniopharyngioma. J Korean Med Sci. 2002;17:254-259.
167. Mottolese C, Szathmari A, Berlier P, Hermier M. Craniopharyngiomas:our experience in Lyon. Childs Nerv Syst. 2005;21:790-798.
168. Takahashi H, Yamaguchi F, Teramoto A. Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children. Childs Nerv Syst. 2005;21:701-704.
169. Hukin J, Steinbok P, Lafay-Cousin L, et al. Intracystic bleomycin therapy for craniopharyngioma in children: the Canadian experience. Cancer. 2007;109:2124-2131.
170. Lafay-Cousin L, Bartels U, Raybaud C, et al. Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma. Report of three cases. J Neurosurg. 2007;107:318-323.
171. Cavalheiro S, Dastoli PA, Silva NS, Toledo S, Lederman H, da Silva MC. Use of interferon α in intratumoral chemotherapy for cystic craniopharyngioma. Childs Nerv Syst. 2005;21:719-724.
172. Cavalheiro S, Di Rocco C, Valenzuela S, et al. Craniopharyngiomas:intratumoral chemotherapy with interferon-α:a multicenter preliminary study with 60 cases. Neurosurg Focus. 2010;28:E12.
173. Bartels U, Laperriere N, Bouffet E, Drake J. Intracystic therapies for cystic craniopharyngioma in childhood. Front Endocrinol (Lausanne). 2012;3:39.
174. Ierardi DF, Fernandes MJ, Silva IR, et al. Apoptosis in α interferon (IFN-α) intratumoral chemotherapy for cystic craniopharyngiomas. Childs Nerv Syst. 2007;23:1041-1046.
175. Müller HL, Gebhardt U, Schröder S, et al. Analyses of treatment variables for patients with childhood craniopharyngioma-results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up. Horm Res Paediatr. 2010;73:175-180.
176. Weiner HL, WisoffJH, Rosenberg ME, et al. Craniopharyngiomas:a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery. 1994;35:1001-1010; discussion 1010-1001.
177. De Vile CJ, Grant DB, Kendall BE, et al. Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J Neurosurg. 1996;85:73-81.
178. Van Effenterre R, Boch AL. Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg. 2002;97:3-11.
179. Moon SH, Kim IH, Park SW, et al. Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas-a study in single institute. Childs Nerv Syst. 2005;21:799-807.
180. Yasargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg. 1990;73:3-11.
181. Regine WF, Kramer S. Pediatric craniopharyngiomas: long term results of combined treatment with surgery and radiation. Int J Radiat Oncol Biol Phys. 1992;24:611-617.
182. Honegger J, Buchfelder M, Fahlbusch R. Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg. 1999;90:251-257.
183. Elliott RE, WisoffJH. Surgical management of giant pediatric craniopharyngiomas. J Neurosurg Pediatr. 2010; 6:403-416.
184. Steno J, Bízik I, Steno A, Matejçík V. Craniopharyngiomas in children: how radical should the surgeon be? Childs Nerv Syst. 2011;27:41-54.
185. Jung TY, Jung S, Moon KS, Kim IY, Kang SS, Kim JH. Endocrinological outcomes of pediatric craniopharyngiomas with anatomical pituitary stalk preservation: preliminary study. Pediatr Neurosurg. 2010;46:205-212.
186. Poretti A, Grotzer MA, Ribi K, Schönle E, Boltshauser E. Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol. 2004;46:220-229.
187. Elliott RE, Jane JA Jr, WisoffJH. Surgical management of craniopharyngiomas in children: meta-analysis and comparison of transcranial and transsphenoidal approaches. Neurosurgery. 2011;69:630-643.
188. Ahmet A, Blaser S, Stephens D, Guger S, Rutkas JT, Hamilton J. Weight gain in craniopharyngioma-a model for hypothalamic obesity. J Pediatr Endocrinol Metab. 2006; 19:121-127.
189. Pereira AM, Schmid EM, Schutte PJ, et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol (Oxf). 2005;62:197-204.
190. Mortini P, Losa M, Pozzobon G, et al. Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg. 2011;114:1350-1359.
191. Kendall-Taylor P, Jönsson PJ, Abs R, et al. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol. 2005;152:557-567.
192. Halac I, Zimmerman D. Endocrine manifestations of craniopharyngioma. Childs Nerv Syst. 2005;21:640-648.
193. Crom DB, Smith D, Xiong Z, et al. Health status in longterm survivors of pediatric craniopharyngiomas. J Neurosci Nurs. 2010;42:323-328.
194. Geffner M, Lundberg M, Koltowska-Häggström M, et al. Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metab. 2004;89:5435-5440.
195. Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT. Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab. 2004;89:81-86.
196. Matson DD. Craniopharyngioma. Clin Neurosurg. 1964; 10:116-129.
197. Phillip M, Moran O, Lazar L. Growth without growth hormone. J Pediatr Endocrinol Metab. 2002;15(suppl 5):1267-1272.
198. Geffner ME. The growth without growth hormone syndrome. Endocrinol Metab Clin North Am. 1996;25:649-663.
199. Costin G, Kogut MD, Phillips LS, Daughaday WH. Cra-niopharyngioma: the role of insulin in promoting postoperative growth. J Clin Endocrinol Metab. 1976;42:370-379.
200. Müller HL, Bueb K, Bartels U, et al. Obesity after childhood craniopharyngioma-German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr. 2001;213:244-249.
201. de Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BG, Stanhope R. Obesity in childhood craniopharyngioma:relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab. 1996;81:2734-2737.
202. Holmer H, Pozarek G, Wirfält E, et al. Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. J Clin Endocrinol Metab. 2010;95:5395-5402.
203. Holmer H, Ekman B, Björk J, et al. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-termGHtherapy. Eur J Endocrinol. 2009;161:671-679.
204. Fjalldal S, Holmer H, Rylander L, et al. Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metab. 2013;98:3253-3262.
205. Müller HL, Handwerker G, Wollny B, Faldum A, Sörensen N. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab. 2002;87:3993-3996.
206. O'Gorman CS, Simoneau-Roy J, Pencharz P, et al. Sleepdisordered breathing is increased in obese adolescents with craniopharyngioma compared with obese controls. J Clin Endocrinol Metab. 2010;95:2211-2218.
207. Müller HL, Heinrich M, Bueb K, et al. Perioperative dexamethasone treatment in childhood craniopharyngioma-influence on short-term and long-term weight gain. Exp Clin Endocrinol Diabetes. 2003;111:330-334.
208. Lek N, Prentice P, Williams RM, Ong KK, Burke GA, Acerini CL. Risk factors for obesity in childhood survivors of suprasellar brain tumours: a retrospective study. Acta Paediatr. 2010;99:1522-1526.
209. Mong S, Pomeroy SL, Cecchin F, Juraszek A, Alexander ME. Cardiac risk after craniopharyngioma therapy. Pediatr Neurol. 2008;38:256-260.
210. Visser J, Hukin J, SargentM, Steinbok P, Goddard K, Fryer C. Late mortality in pediatric patients with craniopharyngioma. J Neurooncol. 2010;100:105-111.
211. Tomita T, Bowman RM. Craniopharyngiomas in children:surgical experience at Children's Memorial Hospital. Childs Nerv Syst. 2005;21:729-746.
212. Fisher PG, Jenab J, Gopldthwaite PT, et al. Outcomes and failure patterns in childhood craniopharyngiomas. Childs Nerv Syst. 1998;14:558-563.
213. Lin LL, El Naqa I, Leonard JR, et al. Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatr. 2008;1:126-130.
214. Kalapurakal JA, Goldman S, Hsieh YC, Tomita T, Marymont MH. Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse. Med Pediatr Oncol. 2003;40:214-218.
215. Scott RM, Hetelekidis S, Barnes PD, Goumnerova L, Tarbell NJ. Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma-a 20-year experience. Pediatr Neurosurg. 1994;21(suppl 1):75-81.
216. Khafaga Y, Jenkin D, Kanaan I, Hassounah M, Al Shabanah M, Gray A. Craniopharyngioma in children. Int J Radiat Oncol Biol Phys. 1998;42:601-606.
217. Lustig RH, Post SR, Srivannaboon K, et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab. 2003;88:611-616.
218. Swaab DF, Gooren LJ, Hofman MA. The human hypothalamus in relation to gender and sexual orientation. Prog Brain Res. 1992;93:205-217; discussion 217-209.
219. Kreier F, Fliers E, Voshol PJ, et al. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat-functional implications. J Clin Invest. 2002;110:1243-1250.
220. Roth C, Wilken B, Hanefeld F, Schröter W, Leonhardt U. Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol. 1998;138:89-91.
221. Harz KJ, Müller HL, Waldeck E, Pudel V, Roth C. Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab. 2003;88:5227-5231.
222. Müller HL, Handwerker G, Gebhardt U, et al. Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness. Cancer Causes Control. 2006;17:583-589.
223. Müller HL, Müller-Stover S, Gebhardt U, Kolb R, Sörensen N, Handwerker G. Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients. J Pediatr Endocrinol Metab. 2006;19(suppl 1):423-429.
224. Müller HL. Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives. Int J Endocrinol. 2010;2010:519607.
225. Mason PW, Krawiecki N, Meacham LR. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med. 2002;156:887-892.
226. Shaikh MG, Grundy RG, Kirk JM. Reductions in basal metabolic rate and physical activity contribute to hypothalamic obesity. J Clin Endocrinol Metab. 2008;93:2588-2593.
227. Kim RJ, Shah R, Tershakovec AM, et al. Energy expenditure in obesity associated with craniopharyngioma. Childs Nerv Syst. 2010;26:913-917.
228. Lustig RH, Hinds PS, Ringwald-Smith K, et al. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2003; 88:2586-2592.
229. Lustig RH. Hypothalamic obesity after craniopharyngioma:mechanisms, diagnosis, and treatment. Front Endocrinol (Lausanne). 2011;2:60.
230. Roth CL, Hunneman DH, Gebhardt U, Stoffel-Wagner B, Reinehr T, Müller HL. Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma. Pediatr Res. 2007;61:496-501.
231. Cohen M, Syme C, McCrindle BW, Hamilton J. Autonomic nervous system balance in children and adolescents with craniopharyngioma and hypothalamic obesity. Eur J Endocrinol. 2013;168:845-852.
232. Roth CL. Hypothalamic obesity in patients with craniopharyngioma:profound changes of several weight regulatory circuits. Front Endocrinol (Lausanne). 2011;2:49.
233. Roth CL, Gebhardt U, Müller HL. Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity (Silver Spring). 2011;19:36-42.
234. Roth CL, Elfers C, Gebhardt U, Müller HL, Reinehr T. Brain-derived neurotrophic factor and its relation to leptin in obese children before and after weight loss. Metabolism. 2013;62:226-234.
235. Roth CL, Enriori PJ, Gebhardt U, et al. Changes of peripheral α-melanocyte-stimulating hormone in childhood obesity. Metabolism. 2010;59:186-194.
236. Roth CL, Aylward E, Liang O, Kleinhans NM, Pauley G, Schur EA. Functional neuroimaging in craniopharyngioma:a useful tool to better understand hypothalamic obesity? Obes Facts. 2012;5:243-253.
237. SchöflC, Schleth A, Berger D, Terkamp C, von zur Mühlen A, Brabant G. Sympathoadrenal counterregulation in patients with hypothalamic craniopharyngioma. J Clin Endocrinol Metab. 2002;87:624-629.
238. Coutant R, Maurey H, Rouleau S, et al. Defect in epinephrine production in children with craniopharyngioma: functional or organic origin? J Clin Endocrinol Metab. 2003; 88:5969-5975.
239. Ismail D, O'ConnellMA, ZacharinMR. Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury. J Pediatr Endocrinol Metab. 2006;19:129-134.
240. Elfers CT, Roth CL. Effects of methylphenidate on weight gain and food intake in hypothalamic obesity. Front Endocrinol (Lausanne). 2011;2:78.
241. Danielsson P, Janson A, Norgren S, Marcus C. Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes. J Clin Endocrinol Metab. 2007;92:4101-4106.
242. Lustig RH. Hypothalamic obesity: causes, consequences, treatment. Pediatr Endocrinol Rev. 2008;6:220-227.
243. Pediatric hypothalamic obesity. http://clinicaltrials.gov/ct2/show/NCT00076362.
244. Müller HL, Gebhardt U, Wessel V, et al. First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. Klin Padiatr. 2007;219:323-325.
245. Inge TH, Pfluger P, Zeller M, et al. Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy. Nat Clin Pract Endocrinol Metab. 2007; 3:606-609.
246. Bingham NC, Rose SR, Inge TH. Bariatric surgery in hypothalamic obesity. Front Endocrinol (Lausanne). 2012; 3:23.
247. Müller HL, Gebhardt U, Maroske J, Hanisch E. Long-term follow-up of morbidly obese patients with childhood craniopharyngioma after laparoscopic adjustable gastric banding (LAGB). Klin Padiatr. 2011;223:372-373.
248. Bretault M, Boillot A, Muzard L, et al. Clinical review:bariatric surgery following treatment for craniopharyngioma:a systematic review and individual-level data metaanalysis. J Clin Endocrinol Metab. 2013;98:2239-2246.
249. Schultes B, Ernst B, Schmid F, Thurnheer M. Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma. Eur J Endocrinol. 2009;161:201-206.
250. Rottembourg D, O'Gorman CS, Urbach S, et al. Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma. J Pediatr Endocrinol Metab. 2009;22:867-872.
251. Bereket A, Kiess W, Lustig RH, et al. Hypothalamic obesity in children. Obes Rev. 2012;13:780-798.
252. Müller HL, Faldum A, Etavard-Gorris N, et al. Functional capacity, obesity and hypothalamic involvement: crosssectional study on 212 patients with childhood craniopharyngioma. Klin Padiatr. 2003;215:310-314.
253. Müller HL, Bruhnken G, Emser A, et al. Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma. Childs Nerv Syst. 2005;21:975-980.
254. Müller HL, Gebhardt U, Faldum A, et al. Functional capacity and body mass index in patients with sellar masses-cross-sectional study on 403 patients diagnosed during childhood and adolescence. Childs Nerv Syst. 2005;21:539-545.
255. Ondruch A, Maryniak A, Kropiwnicki T, Roszkowski M, Daszkiewicz P. Cognitive and social functioning in children and adolescents after the removal of craniopharyngioma. Childs Nerv Syst. 2011;27:391-397.
256. Cavazzuti V, Fischer EG, Welch K, Belli JA, Winston KR. Neurological and psychophysiological sequelae following different treatments of craniopharyngioma in children. J Neurosurg. 1983;59:409-417.
257. Riva D, Pantaleoni C, Devoti M, Saletti V, Nichelli F, Giorgi C. Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngioma. Childs Nerv Syst. 1998;14:179-184.
258. Kiehna EN, Mulhern RK, Li C, Xiong X, Merchant TE. Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy. J Clin Oncol. 2006;24:5283-5290.
259. Carpentieri SC, Waber DP, Scott RM, et al. Memory deficits among children with craniopharyngiomas. Neurosurgery. 2001;49:1053-1058.
260. Sands SA, Milner JS, Goldberg J, et al. Quality of life and behavioral follow-up study of pediatric survivors of craniopharyngioma. J Neurosurg. 2005;103:302-311.
261. Oezyurt J, Thiel CM, Lorenzen A, et al. Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement. J Pediatr. 2014;164:876-881.
262. ColangeloM, Ambrosio A, Ambrosio C. Neurological and behavioral sequelae following different approaches to craniopharyngioma. Long-term follow-up review and therapeutic guidelines. Childs Nerv Syst. 1990;6:379-382.
263. Metzler-Baddeley C, Jones R. Brief communication: cognitive rehabilitation of executive functioning in a case of craniopharyngioma. Appl Neuropsychol. 2010;17:299-304.
264. Hammond JL, Hall SS. Functional analysis and treatment of aggressive behavior following resection of a craniopharyngioma. Develop Med Child Neurol. 2011;53:369-374.
265. Anderson CA, Wilkening GN, Filley CM, Reardon MS, Kleinschmidt-DeMasters BK. Neurobehavioral outcome in pediatric craniopharyngioma. Pediatr Neurosurg. 1997; 26:255-260.
266. Cohen M, Guger S, Hamilton J. Long term sequelae of pediatric craniopharyngioma - literature review and 20 years of experience. Front Endocrinol (Lausanne). 2011; 2:81.
267. Liu AK, Bagrosky B, Fenton LZ, et al. Vascular abnormalities in pediatric craniopharyngioma patients treated with radiation therapy. Pediatr Blood Cancer. 2009;52:227-230.
268. StrippDC, Maity A, Janss AJ, et al. Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys. 2004;58:714-720.
269. Nagata T, Goto T, Ichinose T, Mitsuhashi Y, Tsuyuguchi N, Ohata K. Pathological findings of fusiform dilation of the internal carotid artery following radical dissection of a craniopharyngioma. J Neurosurg Pediatr. 2010;6:567-571.
270. Bendszus M, Sörensen N, Hofmann E, Röll E, Solymosi L. Fusiform dilatations of the internal carotid artery following surgery for pediatric suprasellar tumors. Pediatr Neurosurg. 1998;29:304-308.
271. Regine WF, Mohiuddin M, Kramer S. Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation. Radiother Oncol. 1993;27:13-21.
272. Bülow B, Attewell R, Hagmar L, Malmström P, Nordström CH, Erfurth EM. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J Clin Endocrinol Metab. 1998;83:3897-3904.
273. Cohen M, Bartels U, Branson H, Kulkarni AV, Hamilton J. Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011. Neuro Oncol. 2013;15:767-774.
274. Bartlett JR. Craniopharyngiomas-a summary of 85 cases. J Neurol Neurosurg Psychiatry. 1971;34:37-41.
275. Wara WM, Sneed PK, Larson DA. The role of radiation therapy in the treatment of craniopharyngioma. Pediatr Neurosurg. 1994;21(suppl 1):98-100.
276. Altuntas B, Ozçakar B, Bideci A, Cinaz P. Cirrhotic outcome in patients with craniopharyngioma. J Pediatr Endocrinol Metab. 2002;15:1057-1058.
277. Basenau D, Stehphani U, Fischer G. Development of complete liver cirrhosis in hyperphagia-induced fatty liver [in German]. Klin Padiatr. 1994;206:62-64.
278. Holmer H, Popovic V, Ekman B, Follin C, Siversson AB, Erfurth EM. Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma. Eur J Endocrinol. 2011;165:25-31.
279. Müller HL, Schneider P, Bueb K, et al. Volumetric bone mineral density in patients with childhood craniopharyngioma. Exp Clin Endocrinol Diabetes. 2003;111:168-173.
280. Szeifert GT, Sipos L, Horváth M, et al. Pathological characteristics of surgically removed craniopharyngiomas:analysis of 131 cases. Acta neurochir (Wien). 1993;124:139-143.
281. Adamson TE, Wiestler OD, Kleihues P, Yasargil MG. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg. 1990; 73:12-17.
282. Crotty TB, Scheithauer BW, Young WF Jr, et al. Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg. 1995;83:206-214.
283. Zoicas F, SchöflC. Craniopharyngioma in adults. Front Endocrinol (Lausanne). 2012;3:46.
284. Gautier A, Godbout A, Grosheny C, et al. Markers of recurrence and long-term morbidity in craniopharyngioma:a systematic analysis of 171 patients. J Clin Endocrinol Metab. 2012;97:1258-1267.
285. Puget S, Garnett M, Wray A, et al. Pediatric craniopharyngiomas:classification and treatment according to the degree of hypothalamic involvement. J Neurosurg. 2007; 106:3-12.
286. Puget S. Treatment strategies in childhood craniopharyngioma. Front Endocrinol (Lausanne). 2012;3:64.
287. Trivin C, Busiah K, Mahlaoui N, et al. Childhood craniopharyngioma:greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index. BMC Pediatr. 2009;9:24.
288. Müller HL, Albanese A, Calaminus G, et al. Consensus and perspectives on treatment strategies in childhood craniopharyngioma:results of a meeting of the Craniopharyngioma Study Group (SIOP), Genova, 2004. J Pediatr Endocrinol Metab. 2006;19(suppl 1):453-454.
289. Müller HL, Gebhardt U, Etavard-Gorris N, Kolb R, Warmuth-Metz M, Sörensen N. Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up-recommendations inKRANIOPHARYNGEOM2000. Onkologie. 2005;28:150-156.
290. Sung DI. Suprasellar tumors in children: a review of clinical manifestations and managements. Cancer. 1982;50:1420-1425.
291. Müller HL. KRANIOPHARYNGEOM 2007. Bremen, Oldenburg, Germany: Universitätsverlag Aschenbeck & Isensee. 2007;1-168.
292. Boop FA. Craniopharyngioma. J Neurosurg. 2007; 106(suppl 1):1-2.
293. Spoudeas HA, Saran F, Pizer B. A multimodality approach to the treatment of craniopharyngiomas avoiding hypothalamic morbidity: a UK perspective. J Pediatr Endocrinol Metab. 2006;19(suppl 1):447-451.
294. Mallucci C, Pizer B, Blair J, et al. Management of craniopharyngioma:the Liverpool experience following the introduction of the CCLG guidelines. Introducing a new risk assessment grading system. Childs Nerv Syst. 2012;28:1181-1192.